[Rhabdomyolysis secondary to the interaction of statins with macrolides in a renal transplant patient].
Valero
R
R
Rodrigo
E
E
Zubimendi
J A
JA
Arias
M
M
D000368:Aged; D000924:Anticholesteremic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics; D017291:Clarithromycin / Q000009:adverse effects* / Q000493:pharmacokinetics; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004347:Drug Interactions; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D008658:Inactivation, Metabolic; D016030:Kidney Transplantation; D008297:Male; D011183:Postoperative Complications / Q000139:chemically induced*; D012141:Respiratory Tract Infections / Q000150:complications / Q000188:drug therapy; D012206:Rhabdomyolysis / Q000139:chemically induced*; D019821:Simvastatin / Q000009:adverse effects* / Q000493:pharmacokinetics
D000924:Anticholesteremic Agents; D003577:Cytochrome P-450 Enzyme System; D019821:Simvastatin; C104464:CYP3A protein, human; D051544:Cytochrome P-450 CYP3A; D017291:Clarithromycin
Rabdomiolisis secundaria a interacción de estatinas con macrólidos en un paciente con trasplante renal.